FDA launches new priority review voucher program for select biopharmas

Amblyotech

Novartis Amblyotech
MedTech

Novartis again enters digital apps in 'lazy eye' video game buy

Novartis is taking another stab at the digital therapeutics space by acquiring a small startup developing a video game treatment for lazy eye.
Conor Hale Apr 20, 2020 10:50am